Cardiac Innervation Imaging: Implications for Risk Stratification and Therapeutic Decision-Making

Research output: Contribution to journalReview articleResearchpeer-review

1 Citation (Scopus)


© 2016, Springer Science+Business Media New York. Heart failure (HF) is associated with reduced cardiac sympathetic neuronal uptake of norepinephrine (NE), which can be assessed noninvasively using different radiotracers and planar or single-photon emission computed tomography (SPECT)/positron emission tomography (PET) imaging. Such sympathetic derangement in HF patients has shown to be an indicator of unfavorable prognosis. Therefore, cardiac sympathetic imaging might be useful as an indicator of the effectiveness of the medical therapy and consequently for risk stratification of patients with HF to more effectively guide specific therapies. This article reviews the current status on the subject and evaluates the literature published over recent years.
Original languageEnglish
Article number6
Pages (from-to)1-7
JournalCurrent Cardiovascular Imaging Reports
Issue number2
Publication statusPublished - 1 Feb 2016


  • Cardiac sympathetic imaging
  • Heart failure
  • mIBG
  • Prognosis


Dive into the research topics of 'Cardiac Innervation Imaging: Implications for Risk Stratification and Therapeutic Decision-Making'. Together they form a unique fingerprint.

Cite this